High Throughput Newborn Screening for Sickle Cell Disease – Application of Two-Tiered Testing with a qPCR-Based Primary screen
Klinische Pädiatrie · 01.11.2023 · 235 (06) · 366-372
DOI: 10.1055/a-2153-7789 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.11.2023. Verfasst von Joachim Janda und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Pediatrics, Division of Neuropediatrics and Metabolic Medicine, University Hospital Heidelberg Center of Paediatric and Adolesc…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Infant, Newborn, Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Sickle cell disease (SCD) is a group of hemoglobinopathies with a common point mutation causing the production of sickle cell hemoglobin (HbS). In high-throughput newborn screening (NBS) for SCD, a two-step procedure is suitable, in which qPCR first pre-selects relevant samples that are differentiated by a second method.
Methods
Three NBS centers using qPCR-based primary screening for SCD performed a laboratory comparison. Methods using tandem MS or HPLC were used for differentiation.
Results
In a benchmarking test, 450 dried blood samples were analyzed. Samples containing HbS were detected as reliably by qPCR as by methods established for hemoglobinopathy testing. In a two-step screening approach, the 2nd-tier-analyses have to distinguish the carrier status from pathological variants. In nine months of regular screening, a total of 353,219 samples were analyzed using two-stage NBS procedures. The 1st-tier screening by qPCR reduced the number of samples for subsequent differentiation by>99.5%. Cases with carrier status or other variants were identified as inconspicuous while 78 cases with SCD were revealed. The derived incidence of 1:4,773, is in good agreement with previously published incidences.
Conclusion
In high-throughput NBS for SCD, qPCR is suitable to focus 2nd-tier analyses on samples containing HbS, while being unaffected by factors such as prematurity or transfusions. The substantial reduction of samples numbers positively impacts resource conservation, sustainability, and cost-effectiveness. No false negative cases came to attention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Pediatrics, Division of Neuropediatrics and Metabolic Medicine, University Hospital Heidelberg Center of Paediatric and Adolescent Medicine, Heidelberg, Germany.
- Screening-Laboratory Hannover, Hannover, Germany.
- Laboratory Becker & Colleagues, Munich, Germany.
- Dept. of Clinical Chemistry, Hannover Medical School, Hannover, Germany.
- Division of Laboratory Medicine, Kinderkrankenhaus auf der Bult, Hannover, Germany.
- Department of Conservative Dentistry and Periodontology, Ludwig Maximilians University Munich, Munich, Germany.
ORCID-Profile: Joachim Janda, Rafael Tesorero, Nils Janzen
Zitieren
APA
Janda, J., Hegert, S., Bzdok, J., Tesorero, R., Holtkamp, U., Burggraf, S., Schuhmann, E., Hörster, F., Hoffmann, G. F., Janzen, N., Okun, J. G., Becker, M., & Durner, J. (2023). High Throughput Newborn Screening for Sickle Cell Disease – Application of Two-Tiered Testing with a qPCR-Based Primary screen. Klinische Pädiatrie, 235(06), 366-372. https://doi.org/10.1055/a-2153-7789
Vancouver
Janda J, Hegert S, Bzdok J, Tesorero R, Holtkamp U, Burggraf S, et al. High Throughput Newborn Screening for Sickle Cell Disease – Application of Two-Tiered Testing with a qPCR-Based Primary screen. Klinische Pädiatrie. 2023;235(06):366-372. doi:10.1055/a-2153-7789
BibTeX
@article{Janda2023,
author = {Janda, Joachim and Hegert, Sebastian and Bzdok, Jessica and Tesorero, Rafael and Holtkamp, Ute and Burggraf, Siegfried and Schuhmann, Elfriede and Hörster, Friedrike and Hoffmann, Georg F and Janzen, Nils and Okun, Jürgen G and Becker, Marc and Durner, Jürgen},
title = {High Throughput Newborn Screening for Sickle Cell Disease – Application of Two-Tiered Testing with a qPCR-Based Primary screen},
journal = {Klinische Pädiatrie},
year = {2023},
volume = {235},
number = {06},
pages = {366--372},
doi = {10.1055/a-2153-7789}
}
EUVIMED